UBS Group Lowers Celsius (NASDAQ:CELH) Price Target to $64.00

Celsius (NASDAQ:CELH) had its price target lowered by research analysts at UBS Group from $70.00 to $64.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. UBS Group’s price objective indicates a potential upside of 64.52% from the stock’s current price.

Several other research firms have also recently issued reports on CELH. Roth Mkm lowered their price objective on shares of Celsius from $75.00 to $65.00 and set a “buy” rating for the company in a research report on Wednesday. Jefferies Financial Group reduced their price objective on Celsius from $98.00 to $68.00 and set a “buy” rating on the stock in a report on Monday, July 22nd. Morgan Stanley cut their price target on Celsius from $68.00 to $50.00 and set an “equal weight” rating on the stock in a research note on Wednesday. Stifel Nicolaus reiterated a “buy” rating and set a $65.00 target price on shares of Celsius in a report on Tuesday, July 9th. Finally, B. Riley reduced their price target on shares of Celsius from $80.00 to $73.00 and set a “buy” rating for the company in a report on Wednesday. One analyst has rated the stock with a sell rating, two have given a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $65.91.

Celsius Price Performance

Shares of NASDAQ CELH traded down $0.69 during mid-day trading on Wednesday, hitting $38.90. 553,434 shares of the company’s stock traded hands, compared to its average volume of 5,209,817. The company’s 50-day moving average is $57.06 and its two-hundred day moving average is $69.30. Celsius has a 1 year low of $36.17 and a 1 year high of $99.62. The company has a market capitalization of $9.07 billion, a P/E ratio of 43.51, a PEG ratio of 1.38 and a beta of 1.90.

Celsius (NASDAQ:CELH) last posted its quarterly earnings data on Tuesday, August 6th. The company reported $0.28 earnings per share for the quarter, beating analysts’ consensus estimates of $0.23 by $0.05. The business had revenue of $402.00 million for the quarter, compared to analysts’ expectations of $391.07 million. Celsius had a net margin of 18.63% and a return on equity of 111.29%. The business’s revenue was up 23.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.17 earnings per share. Equities analysts anticipate that Celsius will post 1.05 EPS for the current fiscal year.

Insider Buying and Selling at Celsius

In other news, Director Hal Kravitz sold 16,500 shares of the stock in a transaction on Tuesday, May 14th. The stock was sold at an average price of $90.27, for a total value of $1,489,455.00. Following the sale, the director now directly owns 201,282 shares in the company, valued at $18,169,726.14. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other Celsius news, Director Hal Kravitz sold 16,500 shares of the firm’s stock in a transaction on Tuesday, May 14th. The stock was sold at an average price of $90.27, for a total value of $1,489,455.00. Following the sale, the director now directly owns 201,282 shares in the company, valued at $18,169,726.14. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, major shareholder William H. Milmoe sold 40,000 shares of the stock in a transaction dated Friday, May 17th. The shares were sold at an average price of $92.95, for a total value of $3,718,000.00. Following the completion of the transaction, the insider now owns 226,245 shares in the company, valued at approximately $21,029,472.75. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its position in Celsius by 183.6% during the 4th quarter. Vanguard Group Inc. now owns 13,746,472 shares of the company’s stock worth $749,458,000 after purchasing an additional 8,899,873 shares during the last quarter. Wellington Management Group LLP lifted its holdings in Celsius by 212.2% in the fourth quarter. Wellington Management Group LLP now owns 3,393,586 shares of the company’s stock valued at $185,018,000 after acquiring an additional 2,306,598 shares during the period. Price T Rowe Associates Inc. MD boosted its position in shares of Celsius by 424.9% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 2,793,210 shares of the company’s stock worth $152,287,000 after purchasing an additional 2,261,046 shares in the last quarter. Eagle Asset Management Inc. grew its stake in shares of Celsius by 188.8% during the 4th quarter. Eagle Asset Management Inc. now owns 2,958,771 shares of the company’s stock worth $161,312,000 after purchasing an additional 1,934,400 shares during the period. Finally, Artisan Partners Limited Partnership acquired a new stake in shares of Celsius in the fourth quarter valued at about $101,116,000. Institutional investors and hedge funds own 60.95% of the company’s stock.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.